Consciousness and COVID-19 with Yoshua Bengio - #361
2020-03-30 · 49 min · episode 361 · 14 entities
Asserted relationships
-
→ appeared on The TWIML AI Podcast (formerly This Week in Machine Learning & Artificial Intelligence podcast0.68
evidence rules-v4
Consciousness and COVID-19 with Yoshua Bengio - #361
-
0.55
evidence rules-v4
Feed author/publisher: Sam Charrington
-
0.40
evidence rules-v4
Feed category: Science
-
0.40
evidence rules-v4
Feed category: Technology
-
0.40
evidence rules-v4
Feed category: News
-
0.40
evidence rules-v4
Feed category: Tech News
-
0.40
evidence rules-v4
Feed author/publisher: TWIML
Entities found in this episode
concepts 6
-
0.50
evidence rules-v4
Feed category: Science
-
0.50
evidence rules-v4
Feed category: Tech News
-
0.40
evidence rules-v4
Feed category: Science
-
0.40
evidence rules-v4
Feed category: News
-
0.40
evidence rules-v4
Feed category: Tech News
-
0.35
evidence rules-v4
COVID
companys 4
-
0.70
evidence rules-v4
Feed author/publisher: TWIML
-
0.50
evidence rules-v4
Feed category: Technology
-
0.40
evidence rules-v4
Feed category: Technology
-
0.40
evidence rules-v4
Feed author/publisher: TWIML
persons 3
-
0.72
evidence rules-v4
Consciousness and COVID-19 with Yoshua Bengio - #361
-
0.70
evidence rules-v4
Feed author/publisher: Sam Charrington
-
0.55
evidence rules-v4
Feed author/publisher: Sam Charrington
podcasts 1
-
appeared on The TWIML AI Podcast (formerly This Week in Machine Learning & Artificial Intelligence podcast0.68
evidence rules-v4
Consciousness and COVID-19 with Yoshua Bengio - #361
Episode description as stored
Today we’re joined by one of, if not the most cited computer scientist in the world, Yoshua Bengio, Professor at the University of Montreal and the Founder and Scientific Director of MILA. We caught up with Yoshua to explore his work on consciousness, including how Yoshua defines consciousness, his paper “The Consciousness Prior,” as well as his current endeavor in building a COVID-19 tracing application, and the use of ML to propose experimental candidate drugs.